The lifetime risk of adult‐onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases CS Crowson, EL Matteson, E Myasoedova, CJ Michet, FC Ernste, ... Arthritis & Rheumatism 63 (3), 633-639, 2011 | 724 | 2011 |
T-cell–mediated lysis of endothelial cells in acute coronary syndromes T Nakajima, S Schulte, KJ Warrington, SL Kopecky, RL Frye, JJ Goronzy, ... Circulation 105 (5), 570-575, 2002 | 495 | 2002 |
Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis TA Kermani, J Schmidt, CS Crowson, SR Ytterberg, GG Hunder, ... Seminars in arthritis and rheumatism 41 (6), 866-871, 2012 | 347 | 2012 |
Large-vessel giant cell arteritis: a cohort study F Muratore, TA Kermani, CS Crowson, AB Green, C Salvarani, ... Rheumatology 54 (3), 463-470, 2015 | 342 | 2015 |
Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis TA Kermani, KJ Warrington, CS Crowson, SR Ytterberg, GG Hunder, ... Annals of the rheumatic diseases 72 (12), 1989-1994, 2013 | 331 | 2013 |
Dual-energy CT for the diagnosis of gout: an accuracy and diagnostic yield study T Bongartz, KN Glazebrook, SJ Kavros, NS Murthy, SP Merry, WB Franz, ... Annals of the rheumatic diseases 74 (6), 1072-1077, 2015 | 316 | 2015 |
A randomized, double‐blind trial of abatacept (CTLA‐4Ig) for the treatment of giant cell arteritis CA Langford, D Cuthbertson, SR Ytterberg, N Khalidi, PA Monach, ... Arthritis & rheumatology 69 (4), 837-845, 2017 | 312 | 2017 |
CD4+, CD28− T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems KJ Warrington, S Takemura, JJ Goronzy, CM Weyand Arthritis & Rheumatism: Official Journal of the American College of …, 2001 | 285 | 2001 |
Distribution of arterial lesions in Takayasu's arteritis and giant cell arteritis PC Grayson, K Maksimowicz-McKinnon, TM Clark, G Tomasson, ... Annals of the rheumatic diseases 71 (8), 1329-1334, 2012 | 268 | 2012 |
Rheumatoid arthritis is an independent risk factor for multi-vessel coronary artery disease: a case control study KJ Warrington, PD Kent, RL Frye, JF Lymp, SL Kopecky, JJ Goronzy, ... Arthritis research & therapy 7, 1-8, 2005 | 259 | 2005 |
The epidemiology of antiphospholipid syndrome: a population‐based study A Duarte‐García, MM Pham, CS Crowson, S Amin, KG Moder, RK Pruthi, ... Arthritis & Rheumatology 71 (9), 1545-1552, 2019 | 250 | 2019 |
Prognostic markers of radiographic progression in early rheumatoid arthritis JJ Goronzy, EL Matteson, JW Fulbright, KJ Warrington, A Chang‐Miller, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2004 | 229 | 2004 |
Diagnostic features, treatment, and outcomes of Takayasu arteritis in a US cohort of 126 patients J Schmidt, TA Kermani, AK Bacani, CS Crowson, LT Cooper, EL Matteson, ... Mayo Clinic Proceedings 88 (8), 822-830, 2013 | 227 | 2013 |
Immunoinhibitory checkpoint deficiency in medium and large vessel vasculitis H Zhang, R Watanabe, GJ Berry, A Vaglio, YJ Liao, KJ Warrington, ... Proceedings of the National Academy of Sciences 114 (6), E970-E979, 2017 | 225 | 2017 |
Definitions and reliability assessment of elementary ultrasound lesions in giant cell arteritis: a study from the OMERACT Large Vessel Vasculitis Ultrasound Working Group S Chrysidis, C Duftner, C Dejaco, VS Schäfer, S Ramiro, G Carrara, ... RMD open 4 (1), e000598, 2018 | 201 | 2018 |
Identification of multiple genetic susceptibility loci in Takayasu arteritis G Saruhan-Direskeneli, T Hughes, K Aksu, G Keser, P Coit, SZ Aydin, ... The American Journal of Human Genetics 93 (2), 298-305, 2013 | 201 | 2013 |
Clinical and pathological evolution of giant cell arteritis: a prospective study of follow-up temporal artery biopsies in 40 treated patients JJ Maleszewski, BR Younge, JT Fritzlen, GG Hunder, JJ Goronzy, ... Modern Pathology 30 (6), 788-796, 2017 | 198 | 2017 |
Large-vessel giant cell arteritis: diagnosis, monitoring and management MJ Koster, EL Matteson, KJ Warrington Rheumatology 57 (suppl_2), ii32-ii42, 2018 | 191 | 2018 |
A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility FD Carmona, SL Mackie, JE Martín, JC Taylor, A Vaglio, S Eyre, ... The American Journal of Human Genetics 96 (4), 565-580, 2015 | 188 | 2015 |
Vasculitis associated with tumor necrosis factor-α inhibitors O Sokumbi, DA Wetter, A Makol, KJ Warrington Mayo Clinic Proceedings 87 (8), 739-745, 2012 | 185 | 2012 |